Urine and Plasma Markers of Platelet Activation and Respiratory Symptoms in COPD.
Chronic Obstr Pulm Dis
; 10(1): 22-32, 2023 Jan 25.
Article
en En
| MEDLINE
| ID: mdl-36367951
ABSTRACT
Introduction:
Antiplatelet therapy has been associated with fewer exacerbations and reduced respiratory symptoms in chronic obstructive pulmonary disease (COPD). Whether platelet activation is associated with respiratory symptoms in COPD is unknown.Methods:
Former smokers with spirometry-confirmed COPD had urine 11-dehydro-thromboxane B2 (11dTxB2), plasma soluble CD40L (sCD40L), and soluble P-selectin (sP-selectin) repeatedly measured during a 6- to 9-month study period. Multivariate mixed-effects models adjusted for demographics, clinical characteristics, and medication use evaluated the association of each biomarker with respiratory symptoms, health status, and quality of life.Results:
Among 169 participants (average age 66.5±8.2 years, 51.5% female, 47.5±31 pack years, forced expiratory volume in 1 second percent predicted 53.8±17.1), a 100% increase in 11dTxB2 was associated with worse respiratory symptoms reflected by higher scores on the COPD Assessment Test (ß 0.77, 95% confidence interval [CI] 0.11-1.4) and Ease of Cough and Sputum Clearance Questionnaire ß 0.77, 95%CI 0.38-1.2, worse health status (Clinical COPD Questionnaire ß 0.13, 95%CI 0.03-0.23) and worse quality of life (St George's Respiratory Questionnaire ß 1.9, 95%CI 0.39-3.4). No statistically significant associations were observed for sCD40L or sP-selectin. There was no consistent statistically significant effect modification of the relationship between urine 11dTxB2 and respiratory outcomes by history of cardiovascular disease, subclinical coronary artery disease, antiplatelet therapy, or COPD severity.Conclusions:
In stable moderate-severe COPD, elevated urinary11dTxB2, a metabolite of the platelet activation product thromboxane A2, was associated with worse respiratory symptoms, health status, and quality of life.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Idioma:
En
Revista:
Chronic Obstr Pulm Dis
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos